Spots Global Cancer Trial Database for recurrent small cell lung cancer
Every month we try and update this database with for recurrent small cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00005032 | Lung Cancer | oblimersen sodi... paclitaxel | 18 Years - | University of Chicago | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34 | NCT01176487 | Lung Cancer | questionnaire a... quality-of-life... 3-dimensional c... palliative radi... whole-brain rad... | 18 Years - | Cancer Trials Ireland | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | NCT00087048 | Lung Cancer | topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| Anlotinib in Treatment of Recurrent Small Cell Lung Cancer | NCT03732846 | Recurrent Small... | Anlotinib | 18 Years - | Peking University Cancer Hospital & Institute | |
| Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer | NCT01901653 | Recurrent Small... | Rovalpituzumab ... | 18 Years - | Stemcentrx | |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body | NCT01325753 | Advanced Malign... Extensive Stage... Lung Metastases Recurrent Malig... Recurrent Non-s... Recurrent Small... Stage IV Non-sm... | cryotherapy quality-of-life... | 18 Years - | Wake Forest University Health Sciences | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00005972 | Lung Cancer | gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | NCT00003674 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Veno-occlusive ... | dalteparin standard therap... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT00182689 | Extensive Stage... Recurrent Small... | sorafenib tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | NCT00068289 | Lung Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
| Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | NCT00041171 | Adult Solid Tum... Breast Cancer Head and Neck C... Kidney and Urin... Male Reproducti... Thorax and Resp... | Hypericum perfo... docetaxel placebo | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | NCT00388089 | Lung Cancer Unspecified Adu... | bortezomib topotecan hydro... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | University of California, Davis | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00248482 | Lung Cancer | Cisplatin Gleevec™ irinotecan | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | NCT00068289 | Lung Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer | NCT01457469 | Limited Stage S... Recurrent Small... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... Tobacco Use Dis... | questionnaire a... quality-of-life... counseling inte... internet-based ... telephone-based... educational int... nicotine replac... educational int... | 18 Years - | Wake Forest University Health Sciences | |
| Docetaxel in Treating Patients With Solid Tumors | NCT00003565 | Bladder Cancer Breast Cancer Head and Neck C... Lung Cancer Unspecified Adu... | docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer | NCT00003847 | Lung Cancer | biricodar dicit... doxorubicin hyd... vincristine sul... | 18 Years - | Vertex Pharmaceuticals Incorporated | |
| PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer | NCT00544674 | Lung Cancer | PR104 F-18-fluoromiso... | 18 Years - | Proacta, Incorporated | |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | NCT00019084 | Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum... | 18 Years - | National Cancer Institute (NCI) | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | NCT00003589 | Lung Cancer | cisplatin gemcitabine hyd... paclitaxel | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00083161 | Lung Cancer | cisplatin cyclophosphamid... etoposide | 18 Years - | Gundersen Lutheran Health System | |
| Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer | NCT00470054 | Extensive Stage... Limited Stage S... Recurrent Small... | dasatinib | 18 Years - | National Cancer Institute (NCI) | |
| Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00062010 | Lung Cancer | interferon alph... 13-cis-retinoic... paclitaxel | 18 Years - | Eastern Cooperative Oncology Group | |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00009971 | Lung Cancer | fenretinide | 18 Years - | National Cancer Institute (NCI) | |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | NCT00024076 | Lung Cancer Malignant Mesot... Metastatic Canc... Thymoma and Thy... | radiofrequency ... | - | Jonsson Comprehensive Cancer Center | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | NCT00769990 | Breast Cancer Kidney Cancer Lung Cancer Melanoma Metastatic Canc... Pain Prostate Cancer | genistein radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00005972 | Lung Cancer | gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors | NCT00346385 | Ovarian Cancer Merkel Cell Car... SCLC | BB-10901 | 18 Years - | ImmunoGen, Inc. | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer | NCT00098956 | Extensive Stage... Recurrent Small... | topotecan hydro... 7-hydroxystauro... | 18 Years - | National Cancer Institute (NCI) | |
| Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer | NCT01262560 | Dysphagia Lung Cancer Pain Esophagitis | Manuka honey in... Manuka honey in... Standard suppor... | 18 Years - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00052494 | Lung Cancer | cisplatin imatinib mesyla... irinotecan hydr... | - | University Health Network, Toronto | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00003011 | Lung Cancer | marimastat Placebo | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer | NCT00104754 | Lung Cancer | liposomal SN-38 | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | NCT00078845 | Breast Cancer Lung Cancer Neurotoxicity Ovarian Cancer Prostate Cancer Unspecified Adu... | Amifostine | 18 Years - | M.D. Anderson Cancer Center | |
| Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34 | NCT01176487 | Lung Cancer | questionnaire a... quality-of-life... 3-dimensional c... palliative radi... whole-brain rad... | 18 Years - | Cancer Trials Ireland | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | NCT00084487 | Extensive Stage... Limited Stage S... Recurrent Small... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | NCT00019331 | Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu... | aldesleukin ras peptide can... sargramostim DetoxPC | 18 Years - | National Cancer Institute (NCI) | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer | NCT00014066 | Lung Cancer | hematoporphyrin... brachytherapy | 18 Years - | Roswell Park Cancer Institute | |
| 11C Topotecan PET Imaging | NCT00253461 | Lung Cancer Metastatic Canc... Ovarian Cancer Unspecified Adu... | computed tomogr... positron emissi... 11C topotecan fludeoxyglucose... | 18 Years - | Case Comprehensive Cancer Center | |
| Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | NCT00086827 | Recurrent Small... | romidepsin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride | NCT01416688 | Colorectal Canc... Dermatologic Co... Lung Cancer Therapy-related... | assessment of t... psychosocial as... quality-of-life... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer | NCT00104754 | Lung Cancer | liposomal SN-38 | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00052949 | Recurrent Small... | imatinib mesyla... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | NCT00087048 | Lung Cancer | topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer | NCT01441297 | Small Cell Lung... Small Cell Lung... | BIBF 1120 | 18 Years - | National Cancer Center, Korea | |
| Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer | NCT01803269 | Extensive Stage... Recurrent Small... | topotecan hydro... cyclodextrin-ba... | 18 Years - | University of Chicago | |
| Sunitinib Malate in Treating Patients With Small Cell Lung Cancer | NCT00953459 | Lung Cancer | sunitinib malat... laboratory biom... fludeoxyglucose... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer | NCT01803269 | Extensive Stage... Recurrent Small... | topotecan hydro... cyclodextrin-ba... | 18 Years - | University of Chicago | |
| Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease | NCT01138358 | Dyspnea Lung Cancer Metastatic Canc... | medical chart r... study of socioe... survey administ... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00041015 | Lung Cancer | cisplatin etoposide topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
